Simultaneous quantitation of atenolol, metoprolol, and propranolol in biological matrices via LC/MS : final report / Robert D. Johnson, Russell J. Lewis.
| Author/creator | Johnson, Robert D. |
| Other author | Lewis, Russell J. |
| Other author | United States. Office of Aerospace Medicine. |
| Other author | Civil Aerospace Medical Institute. |
| Format | Electronic |
| Publication Info | Washington, DC : U.S. Dept. of Transportation, Federal Aviation Administration, Office of Aerospace Medicine ; [Ft. Belvoir, VA : Available through the Defense Technical Information Center ; Springfield, VA : Available through the National Technical Information Service, 2005] |
| Description | i, 18 p. : digital, PDF file. |
| Supplemental Content | https://purl.fdlp.gov/GPO/LPS74592 |
| Subjects |
| Summary | Hypertension is a growing medical concern in the United States. With an increasing number of Americans suffering from hypertension every year, the use of antihypertensive medications such as beta-blockers has increased as well. Three beta-blocker medications--atenolol, metoprolol, and propranolol--were among the 200 most prescribed drugs in the United States in 2003, ranked 4, 14, and 165, respectively. Pilots that successfully manage their hypertension either with diet, exercise, and/or medication may remain medically certified to operate an aircraft. However, these pilots are closely monitored to ensure that their hypertension is properly controlled. The FAA classifies approximately 8% of all active civil aviation pilots as "hypertensive with medication." Toxicological evaluation of postmortem samples obtained from pilots is an important part of the investigation of fatal civil aviation accidents. During this evaluation it is not uncommon to detect beta-blocker compounds such as atenolol, metoprolol, or propranolol in the submitted biological samples. In forensic toxicology laboratories, these compounds are most commonly confirmed and/or quantitated by gas chromatography with mass spectrometric detection (GC/MS). Liquid chromatography coupled with mass spectrometric detection (LC/MS), however, is becoming increasingly more prevalent in the field of forensic toxicology and is considered a superior alternative to GC/MS for the analysis of many compounds. There are very few analytical LC/MS methods published for the determination of beta-blockers from biological specimens. Furthermore, we were unable to find any citation for the toxicological determination of beta-blockers in postmortem fluid and tissue specimens using LC/MS; in particular, atmospheric pressure chemical ionization (APCI) in conjunction with ion trap MS. This manuscript describes the validation and application of such a method. |
| General note | Title from PDF t.p. (viewed May 24, 2006). |
| General note | "May 2005." |
| General note | "DOT/FAA/AM-05/10." |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| Bibliography note | Includes bibliographical references (p. 6-7). |
| Other forms | Also available in print. |
| Funding information | Performed by FAA Civil Aerospace Medical Institute under approved task no. AM-B-04-TOX-204 |
| Technical details | Mode of access: Internet from the Office of Aerospace Medicine web site. Address as of 9/28/06: http://www.faa.gov/library/reports/medical/oamtechreports/2000s/media/0510.pdf; current access via PURL. |
| Technical rpt number | DOT/FAA/AM-05/10 |
| GPO item number | 0431-E-04 (online) |
| Govt. docs number | TD 4.210:05/10 |
Availability
| Library | Location | Call Number | Status | Item Actions |
|---|---|---|---|---|
| Electronic Resources | Access Content Online | ✔ Available |